Free Trial

ORIC Pharmaceuticals (ORIC) SEC Filings & 10K Form

ORIC Pharmaceuticals logo
$9.39 -0.36 (-3.69%)
Closing price 06/11/2025 04:00 PM Eastern
Extended Trading
$9.39 0.00 (0.00%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ORIC Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/11/2025
5:37 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
7:18 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:16 PM
ORIC Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
11:22 AM
ORIC Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/05/2025
4:17 PM
ORIC Pharmaceuticals (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13D
06/04/2025
3:32 PM
ORIC Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
05/30/2025
3:35 PM
ORIC Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G
05/28/2025
3:42 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:47 PM
ORIC Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
8:42 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:10 PM
ORIC Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
3:15 PM
ORIC Pharmaceuticals (Filer)
Form ARS
03/20/2025
3:25 PM
ORIC Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2025
4:27 PM
Kunkel Lori Anne (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:30 AM
FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:30 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:43 PM
Dier Mardi (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:44 PM
Heyman Richard A. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:45 PM
Hoerter Steven L. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:46 PM
Kunkel Lori Anne (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:47 PM
ORIC Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:41 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:41 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:42 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:21 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:22 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:23 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
8:31 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:34 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:29 PM
ORIC Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:54 PM
EcoR1 Capital, LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
4:47 PM
Nextech Crossover I GP S.a r.l. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
8:42 AM
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G
08/12/2024
3:20 PM
ORIC Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:10 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:26 PM
ORIC Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:21 PM
Heyman Richard A. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:22 PM
Dier Mardi (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:24 PM
Hoerter Steven L. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Want to front-run Warren Buffett? (Ad)

A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Click here to get Garrett’s Top Four picks now.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ORIC) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners